Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Markets Investing.com By Reuters 01 Jun 2026 17:00 1 min read

Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.